Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease

被引:3
|
作者
Aloi, Marina [1 ]
D'Arcangelo, Giulia [1 ]
Rossetti, Danilo [1 ]
Bucherini, Simone [1 ]
Felici, Enrico [1 ]
Romano, Claudio [1 ]
Martinelli, Massimo [1 ]
Dipasquale, Valeria [1 ]
Lionetti, Paolo [1 ]
Oliva, Salvatore [1 ]
机构
[1] Sapienza Univ Rome, Umberto I Hosp, Rome, Italy
关键词
eosinophilic esophagitis; inflammatory bowel disease; ulcerative colitis; Crohn's disease; prevalence; incidence; children; DIAGNOSIS; PATHOGENESIS; VALIDATION; GUIDELINES; MANAGEMENT; COLITIS;
D O I
10.1093/ibd/izac172
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Lay Summary We investigated the association between pediatric inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE). Our results showed that having an EoE might be associated with a milder IBD disease course, but larger cohort analyses are needed to confirm such result. Background Scarce data have investigated the association between pediatric inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE). We, therefore, aimed to describe the epidemiology and the possible peculiar phenotype and natural history of such an association. Methods Case-control study is based on the Italian Society for Pediatric Gastroenterology (SIGENP) national registry. All children with a combined diagnosis of IBD and EoE were included. The overall prevalence and incidence in 2 periods, 2009 to 2015, and 2016 to 2021, were calculated. Cases were matched with IBD only and EoE only patients in a 1:3:3 ratio. Phenotype and outcomes (courses of steroids, risk of complications, surgery, treatment escalation, and hospitalization) were compared between groups. Results Eleven patients (age 11.2 +/- 2.8 years, Males 91%) with EoE-IBD out of 3090 patients with IBD were identified, resulting in an overall prevalence of 0.35% and an incidence of 0.18% for 2009 to 2015 and 0.45% for 2016 to 2021. Treatment escalation rates for IBD were significantly higher in patients with IBD compared with EoE-IBD at 12- and 24-month follow-up (0% vs 30%, P = .04; and 9% vs 45.5%, P = .03, respectively). Furthermore, patients with IBD were at a significantly higher risk of hospitalization than both EoE-IBD and EoE patients (log rank P < .001). We found no significant differences in major outcomes related to the EoE course in EoE-IBD patients compared with EoE ones. Conclusions The incidence and prevalence of EoE in children with IBD are low, although the incidence seems to be rising in recent years. Having EoE appears to be associated with a milder IBD disease course, whereas having IBD does not seem to affect the natural history of EoE. More data are needed to better define the phenotype of such association.
引用
收藏
页码:1057 / 1064
页数:8
相关论文
共 50 条
  • [31] A Comprehensive Global Population-Based Analysis on the Coexistence of Eosinophilic Esophagitis and Inflammatory Bowel Disease
    Malik, Alexander
    Liu, Benjamin Douglas
    Zhu, Liangru
    Kaelber, David
    Song, Gengqing
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (03) : 892 - 900
  • [32] A Comprehensive Global Population-Based Analysis on the Coexistence of Eosinophilic Esophagitis and Inflammatory Bowel Disease
    Alexander Malik
    Benjamin Douglas Liu
    Liangru Zhu
    David Kaelber
    Gengqing Song
    Digestive Diseases and Sciences, 2024, 69 : 892 - 900
  • [33] Eosinophilic esophagitis associated with infliximab therapy in pediatric patients with inflammatory bowel disease
    Wu, Meng-Che
    Glickman, Jonathan N.
    Winter, Harland S.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2025,
  • [34] Clinical characteristics of Iranian pediatric patients with inflammatory bowel disease
    Fallahi, Gholam-Hossein
    Moazzami, Kasra
    Tabatabaeiyan, Maryam
    Zamani, Mohammad Mehdi
    Asgar-Shirazi, Masoumeh
    Najafi, Mehri
    Motamed, Farzaneh
    Farahmand, Fatemeh
    Khodad, Ahmad
    Khatami, Gholam-Reza
    Rezaei, Nima
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2009, 72 (02) : 230 - 234
  • [35] Cytokine Profile in Children with Inflammatory Bowel Disease
    Toptygina, A. P.
    Semikina, E. L.
    Bobyleva, G. V.
    Miroshkina, L. V.
    Petrichuk, S. V.
    BIOCHEMISTRY-MOSCOW, 2014, 79 (12) : 1371 - 1375
  • [36] Immunization Coverage in Children with Inflammatory Bowel Disease
    Kowalska-Duplaga, K.
    Baranowska-Nowak, M.
    Nescioruk, M.
    Banasiuk, M.
    Karolewska-Bochenek, K.
    Lazowska-Przeorek, I.
    Radzikowski, A.
    Banaszkiewicz, A.
    RESPIRATORY AILMENTS IN CONTEXT, 2019, 1113 : 83 - 88
  • [37] Impact of Sarcopenia on Clinical Course of Inflammatory Bowel Disease in Korea
    Nam, Kwangwoo
    Lee, Jae Yong
    Ko, Yousun
    Kim, Kyung Won
    Lee, Ho-Su
    Hong, Seung Wook
    Park, Jin Hwa
    Hwang, Sung Wook
    Yang, Dong-Hoon
    Ye, Byong Duk
    Byoun, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Park, Sang Hyoung
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2165 - 2179
  • [38] Hepatobiliary manifestations of inflammatory bowel disease in children
    Kucharska, Magdalena
    Daniluk, Urszula
    Kwiatek-Sredzinska, Kamila Agnieszka
    Wasilewska, Natalia
    Filimoniuk, Aleksandra
    Jakimiec, Piotr
    Zdanowicz, Katarzyna
    Lebensztejn, Dariusz Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 5 (03) : 203 - 209
  • [39] Ocular Involvement in Children with Inflammatory Bowel Disease
    Naviglio, Samuele
    Parentin, Fulvio
    Nider, Silvia
    Rassu, Nicolo
    Martelossi, Stefano
    Ventura, Alessandro
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (06) : 986 - 990
  • [40] Obesity Has Minimal Impact on Clinical Outcomes in Children with Inflammatory Bowel Disease
    Zwintscher, Nathan P.
    Horton, John D.
    Steele, Scott R.
    JOURNAL OF PEDIATRIC SURGERY, 2014, 49 (02) : 265 - 268